PostęPy w diagnostyce i leczeniu nabytych zastawkowych wad serca
PostęPy w diagnostyce i leczeniu nabytych zastawkowych wad serca
PostęPy w diagnostyce i leczeniu nabytych zastawkowych wad serca
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
3. Mizuguchi K.A., Fox A.A., Burch T.M. i wsp. Tricuspid and mitral valve carcinoid disease in the setting<br />
of a patent foramen ovale. Anesth Analg 2008;107:1819-21.<br />
4. Boudoulas H., Sparks E.E. ,Wooley C.F. Mitral valvular regurgitation : etiology, pathophysiologic<br />
mechanisms, clinical manifestations. Herz 2006;31:6-13.<br />
5. Enriquez-Sarano M., Akins C.W., Vahanian A. Mitral regurgitation. Lancet 2009;373:1382-94.<br />
6. Turgeman Y., Atar S., Rosenfeld T. The subvalvular apparatus in rheumatic mitral stenosis: methods<br />
of assessment and therapeutic implications. Chest 2003;124:1929-36.<br />
7. Horstkotte D, Niehues R, Strauer BE. Pathomorphological aspects, aetiology and natural history of<br />
acquired mitral valve stenosis. Eur Heart J. 1991;12 Suppl B:55-60.<br />
8. Bekeredjian R., Grayburn P.A. Valvular heart disease: aortic regurgitation. Circulation 2005;112:125-34.<br />
9. Stout K.K., Verrier E.D. Acute valvular regurgitation. Circulation 2009;119:3232-41.<br />
10. Burdick S., Tresch D.D., Komokowski R.A.Cardiac valvular dysfunction associated with Crohn’s<br />
disease in the absence of ankylosing spondylitis. Am Heart J 1989;118:174-6.<br />
11. Waller B.F., Howard J., Fess S. Pathology of aortic valve stenosis and pure aortic regurgitation: a clinical<br />
morphologic assessment – Part II. Clin Cardiol 1994;17:150-6.<br />
12. Ames D.E., Asherson R.A., Coltart J.D. i wsp. Systemic lupus erythematosus complicated by tricuspid<br />
stenosis and regurgitation: successful treatment by valve transplantation. Ann Rheum Dis<br />
1992;51:120-2.<br />
13. Waller B.F., Howard J., Fess S. Pathology of tricuspid valve stenosis and pure tricuspid regurgitation<br />
– Part I. Clin Cardiol 1995;18:97-102.<br />
14. Waller B.F., Howard J., Fess S. Pathology of tricuspid valve stenosis and pure tricuspid regurgitation<br />
– Part II. Clin Cardiol 1995;18:167-174.<br />
15. Iskandar S.B., Ann Jackson S., Fahrig S. i wsp. Tricuspid valve malfunction and ventricular pacemaker<br />
lead: case report and review of the literature. Echocardiography 2006;23:692-697.<br />
16. Bonow R.O., Carabello B.A., Chatterjee K. i wsp. ACC/AHA 2006 guidelines for management of patients<br />
with valvular heart disease. A report of the American College of Cardiology/American Heart<br />
Association Task Force on practice guidelines. JACC 2006;48 (3).<br />
17. Vahanian A., Baumgartner H., Bax J. i wsp. Guidelines on the management of valvular heart disease.<br />
The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology.<br />
Eur Heart J 2007;28:230-268.<br />
18. Yetkin E., Waltenberger J. Molecular mechanisms of aortic stenosis. Int J Cardiol 2009;135:4-13.<br />
19. Borowiec-Kocańda A., Dąbrowski R. Zwężenie zastawki aortalnej – nie tylko leczenie chirurgiczne.<br />
Kardiol Pol 2008;66:443-446.<br />
20. Orłowska-Baranowska E., Stepińska J. Czy stenoza aortalna ma podłoże genetyczne. Kardiol Pol<br />
2007;65:1376-1380.<br />
21. Moura LM, Ramos SF, Zamorano JL i wsp. Rosuvastatin affecting aortic valve endothelium to slow<br />
the progression of aortic stenosis. J Am Coll Cardiol 2007;49:554-561.<br />
22. Cowell SJ, Newby DE, Prescott RJ i wsp. Scottish aortic stenosis and lipid lowering trial, impact on<br />
regression (SALTIRE) investigators. A randomized trial of intensive lipid-lowering therapy in calcific<br />
aortic stenosis. N Engl J Med 2005;352:2389-2397.<br />
23. Rossebo AB, Pedersen TR, Boman K i wsp. Intensive lipid lowering with simvastatin and ezetimibe<br />
in aortic stenosis. N Eng J Med 2008;359:1343-1356.<br />
22
Change language